Difficulty: Medium
Average Score: 65%
Practice
Dopamine at low doses influences mainly:
Correct answer
B
Rationale
In the context of lifespan pharmacology, understanding the effects of dopamine at low doses is crucial for providing safe and effective patient care. The correct answer is B) Dopamine receptors (leads to vasodilation of renal and mesenteric vessels).
Dopamine, when administered at low doses, primarily acts on dopamine receptors. Activation of these receptors leads to vasodilation of renal and mesenteric vessels. This effect is beneficial in improving renal perfusion and blood flow to the mesenteric area, which can be important in conditions such as renal insufficiency or mesenteric ischemia.
Option A) Alpha-adrenoceptors (leads to peripheral vasoconstriction) is incorrect because dopamine at low doses does not primarily act on alpha-adrenergic receptors to cause vasoconstriction.
Option C) Beta-1 adrenoceptors (leads to enhanced cardiac output) is incorrect because dopamine at low doses does not significantly stimulate beta-1 adrenergic receptors to increase cardiac output.
Option D) All of the above is incorrect because dopamine at low doses mainly influences dopamine receptors, rather than alpha-adrenergic or beta-1 adrenergic receptors.
Understanding the specific receptor interactions of dopamine at different doses is important for tailoring pharmacological interventions to individual patient needs. This knowledge can help healthcare providers optimize treatment strategies and minimize adverse effects in patients across the lifespan.
Dopamine, when administered at low doses, primarily acts on dopamine receptors. Activation of these receptors leads to vasodilation of renal and mesenteric vessels. This effect is beneficial in improving renal perfusion and blood flow to the mesenteric area, which can be important in conditions such as renal insufficiency or mesenteric ischemia.
Option A) Alpha-adrenoceptors (leads to peripheral vasoconstriction) is incorrect because dopamine at low doses does not primarily act on alpha-adrenergic receptors to cause vasoconstriction.
Option C) Beta-1 adrenoceptors (leads to enhanced cardiac output) is incorrect because dopamine at low doses does not significantly stimulate beta-1 adrenergic receptors to increase cardiac output.
Option D) All of the above is incorrect because dopamine at low doses mainly influences dopamine receptors, rather than alpha-adrenergic or beta-1 adrenergic receptors.
Understanding the specific receptor interactions of dopamine at different doses is important for tailoring pharmacological interventions to individual patient needs. This knowledge can help healthcare providers optimize treatment strategies and minimize adverse effects in patients across the lifespan.